{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:06:28Z","timestamp":1768532788059,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.peptides.2012.10.014","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T21:45:16Z","timestamp":1352929516000},"page":"89-94","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The cardiovascular effects of a chimeric opioid peptide based on morphiceptin and PFRTic-NH2"],"prefix":"10.1016","volume":"39","author":[{"given":"Meixing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouliang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2012.10.014_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(89)90311-9","article-title":"Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study","volume":"500","author":"Allard","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2012.10.014_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0022-3565(25)10692-7","article-title":"Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat","volume":"274","author":"Allard","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2012.10.014_bib0015","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj080114","article-title":"Opioid ligands with mixed mu\/delta opioid receptor interactions: an emerging approach to novel analgesics","volume":"8","author":"Ananthan","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.peptides.2012.10.014_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1027385522859","article-title":"The inhibitory effects of N\u03c9-nitro-l-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro","volume":"22","author":"Ayers","year":"1997","journal-title":"Neurochem Res"},{"key":"10.1016\/j.peptides.2012.10.014_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/bbrc.1995.1011","article-title":"The role of nitric oxide in the central control of blood pressure","volume":"206","author":"Cabrera","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2012.10.014_bib0030","doi-asserted-by":"crossref","first-page":"F357","DOI":"10.1152\/ajprenal.00261.2005","article-title":"l-NAME, a nitric oxide synthase inhibitor, diminishes oxidative damage in urinary bladder partial outlet obstruction","volume":"290","author":"Conners","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0143-4179(86)90006-5","article-title":"The effect of mu, delta, kappa and epsilon opioid receptor agonists on heart rate and blood pressure of the pithed rat","volume":"8","author":"Eimerl","year":"1986","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2012.10.014_bib0040","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.peptides.2003.10.009","article-title":"Functional properties of Pfr(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors","volume":"24","author":"Engstr\u00f6m","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.10.014_bib0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0735-1097(96)00312-9","article-title":"Endogenous beta-endorphins in hypertension: correlation with 24-h ambulatory blood pressure","volume":"28","author":"Guasti","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0167-0115(82)90140-9","article-title":"\u03b4 versus \u03bc receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats","volume":"4","author":"Hassen","year":"1982","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2012.10.014_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0196-9781(99)00189-8","article-title":"The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF)","volume":"21","author":"Huang","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.10.014_bib0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cne.10246","article-title":"Central administration of neuropeptide FF (NPFF) causes increased neuronal activation and up-regulation of NPFF gene expression in the rat brainstem","volume":"447","author":"Jhamandas","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2826.2003.00869.x","article-title":"Central administration of neuropeptide FF causes activation of oxytocin paraventricular hypothalamic neurones that project to the brainstem","volume":"15","author":"Jhamandas","year":"2003","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.regpep.2012.08.008","article-title":"Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide","volume":"179","author":"Li","year":"2012","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2012.10.014_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(84)90436-9","article-title":"Depressor and bradycardic effect following intrathecal injection of [NMePhe3,d-Pro4]morphiceptin in rats","volume":"99","author":"Li","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0080","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/endo-118-5-1814","article-title":"Opioid-mediated cardiovascular effects of clonidine in spontaneously hypertensive rats: elimination by neonatal treatment with monosodium glutamate","volume":"118","author":"Mosqueda-Garcia","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2012.10.014_bib0085","first-page":"35","article-title":"Central inhibition of nitric oxide synthesis increases blood pressure and heart rate in anesthetized rats","volume":"15","author":"Nurminen","year":"1997","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0196-9781(93)90184-I","article-title":"Comparative effects on blood pressure and heart rate of dynorphin A(1\u201313) in anterior hypothalamic area, posterior hypothalamic area, nucleus tractus solitarius, and lateral cerebral ventricle in the rat","volume":"14","author":"Rabkin","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.10.014_bib0095","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1476-5381.1990.tb14151.x","article-title":"Characterization of 3 inhibitors of endothelial nitric-oxide synthase in vitro and in vivo","volume":"101","author":"Rees","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10641968409062554","article-title":"Opioid peptides and central control of blood pressure","volume":"a6","author":"Reid","year":"1984","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.peptides.2012.10.014_bib0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1073\/pnas.0502090103","article-title":"RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia","volume":"103","author":"Simonin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2012.10.014_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00633196","article-title":"Opioid peptides decrease noradrenaline release and blood pressure in the rabbit at peripheral receptors","volume":"332","author":"Szabo","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0115","doi-asserted-by":"crossref","first-page":"R1453","DOI":"10.1152\/ajpregu.1990.258.6.R1453","article-title":"Central opioid modulation of fetal cardiovascular function: role of mu- and delta-receptors","volume":"258","author":"Szeto","year":"1990","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1440-1681.1991.tb01398.x","article-title":"Normotensive Wistar rats differ from spontaneously hypertensive and renal hypertensive rats in their cardiovascular responses to opioid agonists","volume":"18","author":"Tyszkiewicz","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.peptides.2012.10.014_bib0125","first-page":"51","article-title":"Cardiovascular responses to morphiceptin in spontaneously hypertensive and normotensive rats","volume":"38","author":"Widy-Tyszkiewicz","year":"1986","journal-title":"Pol J Pharmacol Pharm"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112004512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112004512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T22:07:15Z","timestamp":1745186835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978112004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":25,"alternative-id":["S0196978112004512"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2012.10.014","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}